POINT Biopharma Global Inc. SC 13G and SC 13G/A reports

Location
4850 West 78 Th Street, Indianapolis, IN
Fiscal year end
December 31
Data updated at
7/19/2024, 08:53 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2023
SC 13G Report Feb 3, 2023
SC 13G Report THE SCHEDULE 13G Sep 26, 2022
SC 13G/A Report SC 13G/A Feb 15, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report PNT AS OF 12/31/2021 Feb 14, 2022
SC 13G/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13G Feb 14, 2022
SC 13G/A Report Feb 11, 2022
SC 13G/A Report POINT BIOPHARMA GLOBAL INC. Feb 11, 2022
SC 13G/A Report Feb 7, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report SC 13G Jul 20, 2021
SC 13G Report May 10, 2021
SC 13G Report Apr 2, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G Report Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 16, 2021
SC 13G Report THERAPEUTICS ACQUISITION CORP. Feb 12, 2021
SC 13G/A Report Feb 8, 2021
SC 13G Report SEC SCHEDULE 13G Feb 4, 2021
SC 13G Report Feb 2, 2021
SC 13G Report Sep 9, 2020
SC 13G Report SC 13G Jul 20, 2020
SC 13G Report THE SCHEDULE 13G Jul 20, 2020
SC 13G Report SC 13G Jul 20, 2020